The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of ampullary adenocarcinomas and duodenal adenocarcinomas with regard to clinical outcomes and responsiveness to fluoropyrimidine-based chemotherapy.
Michael J. Overman
Disclosure not yet available
Zhi-Qin Jiang
Disclosure not yet available
Aditya Lal
Disclosure not yet available
Jason B. Fleming
Disclosure not yet available
Gauri R. Varadhachary
Disclosure not yet available
James L. Abbruzzese
Disclosure not yet available
Robert A. Wolff
Disclosure not yet available